Citi Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $290

花旗维持Icon PLC(ICLR.US)买入评级，下调目标价至290美元

moomoo资讯 · 01/06 21:34 · 评级/大行评级

Citi analyst Patrick B Donnelly maintains $Icon PLC (ICLR.US)$ with a buy rating, and adjusts the target price from $360 to $290.

According to TipRanks data, the analyst has a success rate of 48.6% and a total average return of 2.6% over the past year.

AnalystRecentRatingAutoNews_206228_20250106_a4d497acc2d7a298672f4427ccfe525a5a46878b_1736253003159645_mm_en

Furthermore, according to the comprehensive report, the opinions of $Icon PLC (ICLR.US)$'s main analysts recently are as follows:

Excluding specific forecasts, an analysis anticipates significant discussion points including the expected recovery's pace and scale in sectors like China and bioprocessing, the implementation of stimulus programs in China, trends in the instrumentation replacement cycle, overall biopharma sector health, and its potential effects on clinical trial demand, as well as the impacts from new governmental policies. The financial revisions for Icon considered the influence of reduced margins due to pass-through effects.
Icon stands as one of the foremost global contract research organizations, aiding biopharmaceutical companies in expediting their drug market introductions. Over recent months, its shares have encountered a 25% decline, attributed to various short-term factors impacting near-term earnings growth and investor outlook. However, the anticipated alleviation of these obstacles is expected to pave the way for a significant rebound in earnings and a reassessment of Icon's market valuation.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

花旗分析师Patrick B Donnelly维持$Icon PLC (ICLR.US)$买入评级，并将目标价从360美元下调至290美元。

根据TipRanks数据显示，该分析师近一年总胜率为48.6%，总平均回报率为2.6%。

AnalystRecentRatingAutoNews_206228_20250106_a4d497acc2d7a298672f4427ccfe525a5a46878b_1736253003159645_mm_sc

此外，综合报道，$Icon PLC (ICLR.US)$近期主要分析师观点如下：

不包括具体预测，一项分析预计会有重要的讨论要点，包括中国和生物加工等行业的预期复苏速度和规模、中国刺激计划的实施、仪器更换周期的趋势、生物制药行业的整体健康状况及其对临床试验需求的潜在影响，以及新政府政策的影响。ICON的财务修订考虑了直通效应导致的利润率下降的影响。
ICON是最重要的全球合同研究组织之一，帮助生物制药公司加快药物市场的推出。最近几个月，其股价下跌了25％，这归因于影响短期收益增长和投资者前景的各种短期因素。但是，预计这些障碍的缓解将为收益的大幅反弹和对ICON市场估值的重新评估铺平道路。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Citi Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $290

Citi Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $290

风险及免责提示

声明